About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
City of Hope
www.cityofhope.org
Breast
Lung
Gastrointestinal
Genitourinary
Leukemia
Lymphoma
Myeloma
Hematologic Malignancies
Head and Neck
General Oncology
Palliative Care
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
J
Breast/Ovarian Cancer Genetic Risk Assessment: BRCA1/2, PALB2 & CHEK2 - Genetic Epidemiology of Hereditary Disease
By
UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics
FEATURING
Jeffrey Weitzel
By
UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics
FEATURING
Jeffrey Weitzel
20 views
February 15, 2021
0 Comments
Login to view comments.
Click here to Login
Featured Video
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
General Oncology
13:16
Total Health
Universal Comprehensive Genomic Profiling and Treatment Planning
Feat.
R. Salgia
17:50
UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics
Breast/Ovarian Cancer Genetic Risk Assessment: BRCA1/2, PALB2 & …
Feat.
J. Weitzel
12:31
City of Hope
2019 ESMO Update: Phase 1 Study of AMG 510, a Novel KRAS G12C Inhibi…
Feat.
M. Fakih